Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse

Janice Froehlich, Brett Hausauer, Stephen Fischer, Bradley Wise, Dennis D. Rasmussen

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Many alcoholics and heavy drinkers undergo repeated cycles of alcohol abstinence followed by relapse to alcohol drinking; a pattern that contributes to escalated alcohol intake over time. In rodents, alcohol drinking that is interspersed with periods of alcohol deprivation (imposed abstinence) increases alcohol intake during reaccess to alcohol. This is termed the "alcohol deprivation effect" or "ADE" and is a model of alcohol relapse in humans. We have previously reported that prazosin reduces alcohol drinking during both brief and prolonged treatment in rats selectively bred for alcohol preference ("P" rats). This study explores whether prazosin prevents alcohol "relapse" in P rats, as reflected by a reduced or abolished ADE. Methods: Adult male P rats were given 24-hour access to food and water and scheduled access to alcohol (15 and 30% v/v solutions presented concurrently) for 2 h/d. After 5 weeks, rats underwent imposed alcohol deprivation for 2 weeks, followed by alcohol reaccess for 2 weeks, and this pattern was repeated for a total of 3 cycles. Rats were injected with prazosin (0, 0.5, 1.0, or 2.0 mg/kg body weight, intraperitoneally) once a day for the first 5 days of each alcohol reaccess cycle. Results: Alcohol intake increased on the first day of each alcohol reaccess cycle, demonstrating the formation of an ADE. The ADE was short-lived, lasting only 1 day, during each of the 3 cycles. Prazosin, in all doses tested, prevented the expression of an ADE in all 3 alcohol reaccess cycles. Conclusions: Prazosin decreases alcohol intake in P rats even in a situation that would be expected to increase alcohol drinking, namely following periods of alcohol deprivation. This suggests that prazosin may be effective in reducing alcohol relapse that often occurs during attempts to achieve permanent alcohol abstinence in treatment-seeking alcoholics and heavy drinkers.

Original languageEnglish
Pages (from-to)1538-1546
Number of pages9
JournalAlcoholism: Clinical and Experimental Research
Volume39
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Prazosin
Animals
Animal Models
Alcohols
Recurrence
Rats
Alcohol Abstinence
Alcohol Drinking
Alcoholics

Keywords

  • Alcohol Deprivation Effect
  • Alcohol Preferring Rats
  • Alcohol Relapse
  • Prazosin

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Toxicology

Cite this

Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse. / Froehlich, Janice; Hausauer, Brett; Fischer, Stephen; Wise, Bradley; Rasmussen, Dennis D.

In: Alcoholism: Clinical and Experimental Research, Vol. 39, No. 8, 01.08.2015, p. 1538-1546.

Research output: Contribution to journalArticle

Froehlich, Janice ; Hausauer, Brett ; Fischer, Stephen ; Wise, Bradley ; Rasmussen, Dennis D. / Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse. In: Alcoholism: Clinical and Experimental Research. 2015 ; Vol. 39, No. 8. pp. 1538-1546.
@article{ebff8ae4f47d4274926f2db54e4c1b35,
title = "Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse",
abstract = "Background: Many alcoholics and heavy drinkers undergo repeated cycles of alcohol abstinence followed by relapse to alcohol drinking; a pattern that contributes to escalated alcohol intake over time. In rodents, alcohol drinking that is interspersed with periods of alcohol deprivation (imposed abstinence) increases alcohol intake during reaccess to alcohol. This is termed the {"}alcohol deprivation effect{"} or {"}ADE{"} and is a model of alcohol relapse in humans. We have previously reported that prazosin reduces alcohol drinking during both brief and prolonged treatment in rats selectively bred for alcohol preference ({"}P{"} rats). This study explores whether prazosin prevents alcohol {"}relapse{"} in P rats, as reflected by a reduced or abolished ADE. Methods: Adult male P rats were given 24-hour access to food and water and scheduled access to alcohol (15 and 30{\%} v/v solutions presented concurrently) for 2 h/d. After 5 weeks, rats underwent imposed alcohol deprivation for 2 weeks, followed by alcohol reaccess for 2 weeks, and this pattern was repeated for a total of 3 cycles. Rats were injected with prazosin (0, 0.5, 1.0, or 2.0 mg/kg body weight, intraperitoneally) once a day for the first 5 days of each alcohol reaccess cycle. Results: Alcohol intake increased on the first day of each alcohol reaccess cycle, demonstrating the formation of an ADE. The ADE was short-lived, lasting only 1 day, during each of the 3 cycles. Prazosin, in all doses tested, prevented the expression of an ADE in all 3 alcohol reaccess cycles. Conclusions: Prazosin decreases alcohol intake in P rats even in a situation that would be expected to increase alcohol drinking, namely following periods of alcohol deprivation. This suggests that prazosin may be effective in reducing alcohol relapse that often occurs during attempts to achieve permanent alcohol abstinence in treatment-seeking alcoholics and heavy drinkers.",
keywords = "Alcohol Deprivation Effect, Alcohol Preferring Rats, Alcohol Relapse, Prazosin",
author = "Janice Froehlich and Brett Hausauer and Stephen Fischer and Bradley Wise and Rasmussen, {Dennis D.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1111/acer.12789",
language = "English",
volume = "39",
pages = "1538--1546",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse

AU - Froehlich, Janice

AU - Hausauer, Brett

AU - Fischer, Stephen

AU - Wise, Bradley

AU - Rasmussen, Dennis D.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Background: Many alcoholics and heavy drinkers undergo repeated cycles of alcohol abstinence followed by relapse to alcohol drinking; a pattern that contributes to escalated alcohol intake over time. In rodents, alcohol drinking that is interspersed with periods of alcohol deprivation (imposed abstinence) increases alcohol intake during reaccess to alcohol. This is termed the "alcohol deprivation effect" or "ADE" and is a model of alcohol relapse in humans. We have previously reported that prazosin reduces alcohol drinking during both brief and prolonged treatment in rats selectively bred for alcohol preference ("P" rats). This study explores whether prazosin prevents alcohol "relapse" in P rats, as reflected by a reduced or abolished ADE. Methods: Adult male P rats were given 24-hour access to food and water and scheduled access to alcohol (15 and 30% v/v solutions presented concurrently) for 2 h/d. After 5 weeks, rats underwent imposed alcohol deprivation for 2 weeks, followed by alcohol reaccess for 2 weeks, and this pattern was repeated for a total of 3 cycles. Rats were injected with prazosin (0, 0.5, 1.0, or 2.0 mg/kg body weight, intraperitoneally) once a day for the first 5 days of each alcohol reaccess cycle. Results: Alcohol intake increased on the first day of each alcohol reaccess cycle, demonstrating the formation of an ADE. The ADE was short-lived, lasting only 1 day, during each of the 3 cycles. Prazosin, in all doses tested, prevented the expression of an ADE in all 3 alcohol reaccess cycles. Conclusions: Prazosin decreases alcohol intake in P rats even in a situation that would be expected to increase alcohol drinking, namely following periods of alcohol deprivation. This suggests that prazosin may be effective in reducing alcohol relapse that often occurs during attempts to achieve permanent alcohol abstinence in treatment-seeking alcoholics and heavy drinkers.

AB - Background: Many alcoholics and heavy drinkers undergo repeated cycles of alcohol abstinence followed by relapse to alcohol drinking; a pattern that contributes to escalated alcohol intake over time. In rodents, alcohol drinking that is interspersed with periods of alcohol deprivation (imposed abstinence) increases alcohol intake during reaccess to alcohol. This is termed the "alcohol deprivation effect" or "ADE" and is a model of alcohol relapse in humans. We have previously reported that prazosin reduces alcohol drinking during both brief and prolonged treatment in rats selectively bred for alcohol preference ("P" rats). This study explores whether prazosin prevents alcohol "relapse" in P rats, as reflected by a reduced or abolished ADE. Methods: Adult male P rats were given 24-hour access to food and water and scheduled access to alcohol (15 and 30% v/v solutions presented concurrently) for 2 h/d. After 5 weeks, rats underwent imposed alcohol deprivation for 2 weeks, followed by alcohol reaccess for 2 weeks, and this pattern was repeated for a total of 3 cycles. Rats were injected with prazosin (0, 0.5, 1.0, or 2.0 mg/kg body weight, intraperitoneally) once a day for the first 5 days of each alcohol reaccess cycle. Results: Alcohol intake increased on the first day of each alcohol reaccess cycle, demonstrating the formation of an ADE. The ADE was short-lived, lasting only 1 day, during each of the 3 cycles. Prazosin, in all doses tested, prevented the expression of an ADE in all 3 alcohol reaccess cycles. Conclusions: Prazosin decreases alcohol intake in P rats even in a situation that would be expected to increase alcohol drinking, namely following periods of alcohol deprivation. This suggests that prazosin may be effective in reducing alcohol relapse that often occurs during attempts to achieve permanent alcohol abstinence in treatment-seeking alcoholics and heavy drinkers.

KW - Alcohol Deprivation Effect

KW - Alcohol Preferring Rats

KW - Alcohol Relapse

KW - Prazosin

UR - http://www.scopus.com/inward/record.url?scp=84937713652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937713652&partnerID=8YFLogxK

U2 - 10.1111/acer.12789

DO - 10.1111/acer.12789

M3 - Article

VL - 39

SP - 1538

EP - 1546

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 8

ER -